MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2017 International Congress

    General Anesthesia and Parkinson’s Disease

    C.-W. CHEN, K.-B. CHEN, Y.-C. KUO (TAICHUNG, Taiwan)

    Objective: Postoperative cognitive dysfunction is common among the elderly. These changes may even be so severe that some elderly people actually become demented after undergoing…
  • 2017 International Congress

    A PSP-like phenotype accompanies rapidly progressive dementia

    M. Dale, D. Erten-Lyons, F. Bittner, H.-Y. Jong, D. Bourdette, R. Woltjer (Charleston, SC, USA)

    Objective: We describe a patient with a progressive supranuclear palsy (PSP)-like phenotype and a rapidly progressive dementia, who was found to have an unknown CSF…
  • 2017 International Congress

    Non-motor symptoms in ACDY5-associated disease

    C. Amlang, M. Vidailhet, M. Amlang (Bronx, NY, USA)

    Objective: To describe non-motor symptoms in a case of ACDY5-associated disease. Background: The hereditary dyskinesia syndrome caused by an ACDY5 mutation was first described in…
  • 2017 International Congress

    RBD predicts the cognitive impairment in Parkinson’s disease

    E. Stefanova, T. Stojkovic, I. Stankovic, V. Kostic (Belgrade, Serbia)

    Objective: To assess the relationship between the presence of Rapid eye movement  sleep and behavior disorders RBD and the cognitive decline of non-demented patients with PD in…
  • 2017 International Congress

    Cognitive strategy use during daily activities in people with Parkinson’s Disease

    I. Sturkenboom, E. Steultjens, M. Nott, C. Chapparo (Nijmegen, Netherlands)

    Objective: To identify difficulties in cognitive strategy use observed in people with Parkinsons’s disease (PD) during performance of everyday activities. Background: People use cognitive strategies…
  • 2017 International Congress

    Prediction of cognitive progression in Parkinson’s disease using three cognitive screening measures

    C. Nazor, C. Zabetian, C. Johnson, B. Fish, J. Quinn, K. Chung, A. Peterson-Hiller, S.-C. Hu, T. Montine, J. Leverenz, K. Edwards, B. Cholerton (Seattle, WA, USA)

    Objective: To assess the utility of commonly used cognitive screening tools in predicting the transition to mild cognitive impairment (MCI) and/or dementia (PDD) in Parkinson’s…
  • 2017 International Congress

    Stabile cognitive profile one year after subthalamic nucleus deep brain stimulation in patients with advanced Parkinson’s disease

    T. Remšak, A. Bujisić, S. Šešok, S. Brezovar, A. Pražnikar, M. Kramberger, D. Georgiev, D. Flisar, K. Boetzel, J. Mehrkens, M. Benedičič, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: To prospectively study the cognitive functions in Parkinson’s disease (PD) patients treated with deep brain stimulation of subthalamic nucleus (STN DBS). Background: STN DBS is a…
  • 2017 International Congress

    Understanding neural activation in semantic fluency in Parkinson’s disease with mild cognitive impairment

    J.H. Julia, K. McMahon, D. Copland, G. Byrne, A. Toft, L. Mithcell, J. O'Sullivan, N. Dissanayaka (Herston, Australia)

    Objective:  To identify neural mechanisms relating to semantic fluency deficits in PD-MCI and to establish possible neuroimaging markers for Parkinson’s disease (PD) with dementia.  Background:…
  • 2017 International Congress

    Evaluation of SV2A expression with [18F]MNI-944 PET imaging in healthy controls (HC) and Parkinson disease (PD)

    D. Russell, D. Alagille, V. Carroll, M. Thompson, J. Madonia, O. Barret, C. Constantinescu, J. Seibyl, K. Marek, G. Tamagnan (New Haven, CT, USA)

    Objective: To evaluate [18F]MNI-944, a highly selective synaptic SV2A PET imaging tracer, as a biomarker for longitudinal studies in early PD.  Background: PD symptoms manifest…
  • 2017 International Congress

    Interrelation between chronic pain syndrome and cognitive and affective disturbances in patients with Parkinson’s disease

    K. Stepanchenko (Kharkiv, Ukraine)

    Objective: To study interrelation of chronic pain syndrome and cognitive and affective disorders in patients with PD Background: Parkinson's disease (PD) is characterized by well-known…
  • « Previous Page
  • 1
  • …
  • 105
  • 106
  • 107
  • 108
  • 109
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley